WELCOME TO OUR COMPANY
Shandong Zhanhua Purun Pharmaceutical Co., Ltd. is a medical chemical enterprise under preparation. The enterprise is a limited liability company with a registered capital of 3 million yuan. The investor has been engaged in the management of the chemical industry for more than 20 years and has rich experience in industry management and production and operation.
The first phase of the company’s construction of 4 production workshops, while supporting the construction of various auxiliary production facilities, of which storage facilities include Class A warehouses, raw materials warehouses, finished product warehouses, hardware warehouses and storage tank areas, etc. The production supporting facilities include refrigerators, Boiler room, generator, circulating water system, electromechanical workshop, high and low voltage transformer and power distribution facilities. At the same time, there are supporting construction of wastewater treatment facilities and exhaust gas treatment facilities of the whole plant, as well as complete fire protection system facilities, as well as office spaces, staff canteens, dormitories and other life Complete supporting facilities. At present, the infrastructure construction of the two workshops is basically completed, and equipment installation is in progress. The equipment installation and commissioning will be completed before the end of the month. The establishment of the safety evaluation is under review, and the establishment should be passed this week. Then proceed to the safety design special paper, which can be submitted for trial production after passing the special paper. It is expected to start trial production at the end of August.
The newly established Shandong Zhanhua Purun Pharmaceutical Co., Ltd. is located in Zhanhua Binhai Industrial Park, with a total planned investment of 100 million yuan. The company will build an annual output of 4000 tons of iron phosphate and 400 tons of 2,3-dichloropyridine in the first phase. , 100 tons of S-cyclopropanoic acid, 100 tons of CKE-3, 100 tons of chlorthalidone and other product production lines, the first phase invested 60 million yuan, and the trial production report is approved and the trial production is expected at the end of August. By the end of the year, the output value can reach 50 million yuan, realizing a profit of 2 million yuan. The trial production employs about 100 people. Next year, the output value is planned to reach 150 million to 200 million yuan, to achieve a profit of 10 million yuan, and employ about 300 people.